Dr. Timothy Shenkang Chang, MD, PhD

Dr. Chang practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Chang's NPI, 1710383146, was assigned on November 12, 2014. Dr. Chang graduated from University of Wisconsin-Madison in 2014. Dr. Chang holds California license A137522.

Dr. Chang's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Chang's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Chang is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Neurology. Dmand AI also links Dr. Chang to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chang practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Chang's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Chang is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Chang is licensed in California.

Dmand AI lists alzheimer's disease, essential tremor, multiple sclerosis, non-alzheimer's dementia (chronic) and parkinson's disease among the conditions Dr. Chang treats.

CMS data shows 137 Medicare services from Dr. Chang across 4 procedure codes in 2024, for 98 Medicare patients. Medicare paid $17,252 for them.

CMS counts 98 Medicare patients who saw Dr. Chang in 2024. The largest group is 75 to 84, with 48 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chang's median patient age at 69, with 49% women.

In 2024, Dr. Chang wrote 539 Medicare Part D claims for 75 patients. 97% of them were for generic drugs. CMS names the drug for 411 of them, across 15 drugs with 11 or more claims each, at $31,851 in total drug cost. In 2023, CMS named 399 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Chang for performance year 2024, reported as part of a group. Dr. Chang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chang as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 18 papers to Dr. Chang, published from 2012 to 2025. 2014 was the busiest year, with 2. The most frequent topics are Asthma and Sodium. Dr. Chang's most frequent co-authors are Theresa W. Guilbert, MD, Adam L. Boxer, MD and Kelly Jean Cowan, MD.

CMS Open Payments shows 12 general payments to Dr. Chang from 3 drug and device companies from 2019 to 2025. Travel and lodging make up the largest share, 87% of the total. Abbvie Inc. paid the most, $969. It also lists 1 research payment totaling $1,266 in 2019.

Dr. Chang graduated from University of Wisconsin-Madison in 2014.

Dr. Chang is in network with 6 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.